Development and evaluation of film coated aceclofenac and chlorzoxazone tablet with enhanced dissolution rate

被引:4
|
作者
Jain S. [1 ,2 ]
Jain A. [2 ]
Jain A. [2 ]
Shrivastava S. [2 ]
Jain A.K. [2 ]
机构
[1] School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal
[2] Bhagyoday Tirth Pharmacy College, Sagar, 470002, M.P.
关键词
Aceclofenac; Chlorzoxazone; Dissolution; Film coating; HPLC; HPMC (E5 LV);
D O I
10.1007/s40005-016-0238-z
中图分类号
学科分类号
摘要
Out of many complications two major problems facing in formulation industry are poor solubility and short half-life of drugs which results into poor bioavailability after oral administration. Solid dosage forms are coated for a number of reasons, the most important of which is controlling the release profiles and bioavailability of the active ingredient. Thus the development of a significant dissolution procedure for drug products with limited water solubility has been a challenge to the pharmaceutical industry. Aceclofenac (Biopharmaceutical classification Class II drug) is a novel non-steroidal anti-inflammatory drugs (NSAIDs) having anti-inflammatory and analgesic properties, and is widely used in the treatment of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. The investigation revealed that there is no official dissolution medium available in the literature. The objective of present study is to formulate film coated tablet of Aceclofenac and Chlorzoxazone having short half-life by coating with hydroxyl propyl methyl cellulose (E5 LV). Then the formulated tablets were evaluated for its physicochemical properties and in vitro release studies. The incorporation of drugs into polymer matrices is considered a valid tool in order to optimize insufficient features of the drug molecule, like solubility, stability or toxic effects. In the present work, the incorporation of aceclofenac was performed in inert HPMC and there was no chemical interaction between the drug and polymers as concluded from the FTIR studies. In the present study, parameters such as solubility, medium pH, surfactant type, dissolution behavior of formulations, stability, and discriminatory effect of dissolution testing in different dissolution mediums were studied for the selection of a proper dissolution medium. The drug showed an enhanced release rate in the dissolution media containing pH 6.8 phosphate buffer, 900 ml with 0.5 % sodium lauryl sulphate at 75 rpm for 60 min and thus was chosen as the discriminating dissolution method for film coated aceclofenac formulation. It was found that greater than 80 % of the label amount is released over 60 min. © 2016, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码:467 / 474
页数:7
相关论文
共 50 条
  • [21] Dissolution Rate Enhancement of Fenofibrate Using Liquisolid Tablet Technique. Part II: Evaluation of In Vitro Dissolution Profile Comparison Methods.
    Karmarkar, Amrit B.
    Gonjari, Indrajeet D.
    Hosmani, Avinash H.
    Dhabale, Pandurang N.
    Bhise, Satish B.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2009, 28 (04): : 538 - 543
  • [22] Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets
    Mitrevska, Ivana
    Achkoska, Tina
    Brezovska, Katerina
    Toshev, Krume
    Dimitrovska, Aneta
    Ugarkovic, Sonja
    JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2019, 2019
  • [23] Development and Evaluation of Fenofibrate Surface Solid Dispersion for Improved Solubility and Dissolution Rate
    Hosmani, Avinash Hanmant
    Patil, Nikhil Dilip
    Pawar, Arti Achut
    Honmane, Sandip Mohan
    Thorat, Yogesh Shripad
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (02) : 446 - 452
  • [24] Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology
    Ando, Masaki
    Kojima, Sayaka
    Ozeki, Yuichi
    Nakayama, Yukiharu
    Nabeshima, Toshitaka
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (01) : 99 - 107
  • [25] Development and evaluation of press-coated salbutamol sulfate tablet for delayed-release dosage forms
    Wang, J.
    Cui, P.
    Luo, Q.
    Wang, L.
    Li, S.
    Zhang, X.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (04) : 335 - 340
  • [26] Development of Enteric Coated Bioadhesive Matrix Tablet of Lornoxicam: in Vitro - in Vivo Evaluation in Healthy Human Volunteers
    Aher, Kiran B.
    Bhavar, Girija B.
    Joshi, Hemant P.
    Chaudhari, Sanjay R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2014, 4 (03): : 150 - 156
  • [27] Evaluation and comparison of alternative dissolution tests in the development of chewable tablet for short-term treatment of the oesophageal infection
    Zhang, L.
    Batchelor, H. K.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A46 - A47
  • [28] Development of a fast dissolving sublingual film containing meloxicam nanocrystals for enhanced dissolution and earlier absorption
    Song, Qing
    Shen, Chengying
    Shen, Baode
    Lian, Wangquan
    Liu, Xiao
    Dai, Bo
    Yuan, Hailong
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 43 : 243 - 252
  • [29] Development of pH shift bicarbonate buffer dissolution test using floating lid and its feasibility for evaluating enteric-coated tablet
    Matsui, Fumiya
    Sakamoto, Aoi
    Sugano, Kiyohiko
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 83
  • [30] Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack
    Kollipara, Sivacharan
    Prabhat, Pankaj Kumar
    Saha, Paramita
    Gupta, Saurabh
    Naidu, Venkat Ramana
    Ahmed, Tausif
    AAPS PHARMSCITECH, 2024, 26 (01):